XML 55 R42.htm IDEA: XBRL DOCUMENT v3.8.0.1
Divestitures and Sale of License Rights (Narrative) (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended
Jul. 07, 2016
Sep. 30, 2016
Aug. 31, 2016
Dec. 31, 2014
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Long Lived Assets Held-for-sale [Line Items]                
Pre-tax gain (loss) on sales         $ 0 $ 496 $ 0 $ (54,957)
Disposal group, held-for-sale, not discontinued operations | Pediacare, New Skin and Fiber Choice | Cough and Cold, Dermatologicals, and Gastrointestinal Products Group | North American OTC Healthcare                
Long Lived Assets Held-for-sale [Line Items]                
Proceeds from sale of divestiture $ 40,000              
Pre-tax gain (loss) on sales           $ (700)   $ (56,200)
Disposal group, held-for-sale, not discontinued operations | Dermoplast | Cough and Cold, Dermatologicals, and Gastrointestinal Products Group | North American OTC Healthcare                
Long Lived Assets Held-for-sale [Line Items]                
Deposit for agreement to purchase   $ 1,250            
Comet Brand                
Long Lived Assets Held-for-sale [Line Items]                
Proceeds from early buy-out of intangible assets       $ 10,000        
Royalty revenue       $ 1,000        
Proceeds from sale of intangible assets     $ 11,000          
Gain sale of intangible assets     1,200          
Intangible assets reduction     $ 9,000